Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
about
Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapiesComparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data.Type D personality is a predictor of poor emotional quality of life in primary care heart failure patients independent of depressive symptoms and New York Heart Association functional class.Developing therapies for heart failure with preserved ejection fraction: current state and future directionsSleep and health-related quality of life in heart failure.Predictors of heart failure in patients with stable coronary artery disease: a PEACE study.Comparison of health-related quality of life between American and Taiwanese heart failure patientsDarbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial.Symptom-Hemodynamic Mismatch and Heart Failure Event Risk.Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).Gender-Specific Physical Symptom Biology in Heart FailurePrevalence and characteristics of multiple psychiatric disorders in cardiac rehabilitation patientsThe Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection FractionPatients with heart failure with preserved ejection fraction and low levels of natriuretic peptides.Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.Quality of Life for Saudi Patients With Heart Failure: A Cross-Sectional Correlational StudyCost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure'It could be worse ... lot's worse!' Why health-related quality of life is better in older compared with younger individuals with heart failure.Health-related quality of life in elderly patients hospitalized with chronic heart failure.Poor sleep and impaired self-care: towards a comprehensive model linking sleep, cognition, and heart failure outcomes.Health-related quality of life of patients with severe heart failure. A cross-sectional multicentre study.Symptom burden in heart failure: assessment, impact on outcomes, and management.Cognitive Function Does Not Impact Self-reported Health-Related Quality of Life in Heart Failure Patients.Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients.Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations.Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.Factors associated with quality of life in Arab patients with heart failure.Evaluation of Quality of Life in Patients with and without Heart Failure in Primary Care.Quality of life in patients with chronic heart failure and their carers: a 3-year follow-up study assessing hospitalization and mortality.Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection Fraction.The impact of frailty on health related quality of life in heart failure.Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial.High intensity, interval exercise improves quality of life of patients with chronic heart failure: a randomized controlled trial.A tentative interpretation of the TOPCAT trial based on randomized evidence from the brain natriuretic peptide stratum analysis.Impact of diabetes mellitus on quality of life in patients with congestive heart failure.Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction.Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.[Measure of disease impact: instrument construct validity in patients with coronary artery disease].
P2860
Q27000263-52FC3C7A-39F4-4A78-9D60-36CCF3274805Q30661992-AF40ACF5-D596-47CD-BB76-976424A329F0Q33516689-F09EDD62-6B29-4103-B5B8-5B684D7531D4Q33619172-498F8FC9-1B03-4E8E-97B1-230C917BB628Q33639223-951706B3-6801-4D6F-93BD-42A166CE63FFQ34066582-15953601-0814-44D2-802D-CA11F48620F9Q34437117-36D665FD-98DC-4EFB-BB24-9F7038C2A6A4Q34627387-285F55F2-1EED-49D2-B5E8-69E1D3CD61EFQ34751907-B91FFC77-0DA2-47C9-9B53-AE6A6BA71AE4Q34799449-7AE53751-2A6E-400F-9C68-7F0ABB49F84EQ35035016-2F5CE1D5-C8EC-49A9-885D-E9B855143F63Q35449312-399B4B6A-4005-4307-9687-057025409643Q35653775-38BAD480-768E-4552-B454-4D2AFBF05A3CQ36584873-D43463B3-FC80-4D0E-88E2-1A71F248DBAEQ36698463-E929F2C8-777F-41CA-96A6-990690C82754Q36707966-84F553FD-A0B9-45B7-90C7-07130DC871E5Q36718490-9AD95260-7FDB-4FE3-A4A0-27E28C9B9A7FQ36853325-1C46FC95-1D0E-429C-BD97-A129DEF6E3ADQ37099093-77EA0C9F-ED94-4BB1-B76E-454699D50ADDQ37320933-E595B5B3-C7DB-4DF7-8DD4-3A8078C3BD14Q37457026-035B5C94-5754-4108-9AA4-B5FF83FF6918Q38045937-1DFDC251-E44C-426C-BC6E-2A62D52D575EQ38945834-6BB63276-D551-4FA5-88CA-F47BD7D5413BQ38989365-EDC2EA81-C384-429D-B71A-3DD97A66A94AQ39038931-9AB165EA-1445-431B-8D31-D4C056ED13A8Q39140267-90CC8BDC-36F3-4336-9100-46D11EA39337Q39237012-07A88864-56A8-4D5E-B98E-428107D72075Q39698282-25D8938A-0955-485D-844B-D6B66CF13AC8Q41626908-C9DEF7BC-4906-46E7-A365-74282C5F4CA3Q45070887-F427835B-3288-47D3-AF02-FAE7A516E859Q46240569-D9A78297-6A6D-495C-90E6-F12A61542176Q46458822-20FBE9D9-EA4E-4C2D-A081-7C2C8404C00AQ48083134-8C0715AC-661D-4AFE-8680-862B55CCAF53Q48159683-D06B67FA-EB9E-46EE-8EB4-09EF7078DE4FQ48521572-62FAA82E-2B11-4719-9B5F-91CC2D6D8C92Q48568344-B024AA32-C5FD-4913-9FA7-87799E387B8BQ48639643-E2C29B8C-E357-4AB0-BC59-5779C30B2D5BQ51816484-EB725A9E-C0CE-407E-8DBB-80B04BA73EF8Q52838302-24BDF8F7-E58A-4DD6-B26E-AC644D5F43E3Q54483500-530A121F-286A-455A-868C-E2D84E42E34D
P2860
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Characterization of health-rel ...... ow ejection fraction in CHARM.
@en
Characterization of health-rel ...... ow ejection fraction in CHARM.
@nl
type
label
Characterization of health-rel ...... ow ejection fraction in CHARM.
@en
Characterization of health-rel ...... ow ejection fraction in CHARM.
@nl
prefLabel
Characterization of health-rel ...... ow ejection fraction in CHARM.
@en
Characterization of health-rel ...... ow ejection fraction in CHARM.
@nl
P2093
P2860
P50
P1476
Characterization of health-rel ...... ow ejection fraction in CHARM.
@en
P2093
Bertil Olofsson
CHARM Investigators
Eileen O'Meara
Eldrin F Lewis
Eric L Michelson
Gervasio A Lamas
James B Young
Jeffrey L Probstfield
John J V McMurray
Jonas Carlsson
P2860
P356
10.1016/J.EJHEART.2006.10.012
P577
2006-12-21T00:00:00Z